Effect of anti-lymphocyte antibody induction therapy on renal allograft survival
- 1 May 1999
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (3) , 9S-11S
- https://doi.org/10.1016/s0041-1345(99)00094-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Effect of Antilymphocyte Induction Therapy on Renal Allograft SurvivalAnnals of Internal Medicine, 1998
- Effect of anti-lymphocyte induction therapy on renal allograft survivalJournal of the American Society of Nephrology, 1997
- A PROSPECTIVE RANDOMIZED COMPARISON OF QUADRUPLE VERSUS TRIPLE THERAPY FOR FIRST CADAVER TRANSPLANTS WITH IMMEDIATE FUNCTIONTransplantation, 1993
- A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATIONTransplantation, 1993
- THE LONG-TERM EFFECTS OF PROPHYLACTIC OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY TRANSPLANTATION—A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED STUDYTransplantation, 1992
- Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1990
- A COMPARISON OF THE EFFECTS OF CYCLOSPORINE VERSUS ANTILYMPHOCYTE GLOBULIN ON DELAYED GRAFT FUNCTION IN CADAVER RENAL TRANSPLANT RECIPIENTSTransplantation, 1989
- Complications and Monitoring of OKT3 TherapyAmerican Journal of Kidney Diseases, 1988
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- LOW-DOSE MAINTENANCE PREDNISONE AND ANTILYMPHOBLAST GLOBULIN FOR THE TREATMENT OF ACUTE REJECTIONTransplantation, 1983